{
    "clinical_study": {
        "@rank": "78963", 
        "arm_group": [
            {
                "arm_group_label": "ContiPress vs. 3M", 
                "arm_group_type": "Experimental", 
                "description": "ContiPress vs. 3M passive and during exercise"
            }, 
            {
                "arm_group_label": "ContiPress vs. Mobil-O-Graph", 
                "arm_group_type": "Experimental", 
                "description": "ContiPress vs. Mobil-O-Graph passive, then oscillometric passive, then oscillometric for 24 hrs every 15 mins."
            }
        ], 
        "brief_summary": {
            "textblock": "The primary purpose of this investigation is to validate the performance and safety of the\n      Investigational Device (ID) against a validated and legally cleared device for measuring\n      Blood Pressure (BP). The secondary purpose is to validate the performance of the ID over a\n      period of 24 hours against a validated and legally cleared device for Ambulatory Blood\n      Pressure Monitoring (ABPM)."
        }, 
        "brief_title": "A Novel Non-interfering Arterial Blood Pressure Monitoring Device", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hypertension", 
            "Hypotension", 
            "Healthy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hypertension", 
                "Hypotension"
            ]
        }, 
        "detailed_description": {
            "textblock": "The clinical investigation is conducted as a controlled (subject as own control),\n      prospective, randomised, comparative investigation in a population with a representative\n      spread of BPs to ensure that the ID performs as good as current marketed and approved\n      devices. The study will be conducted in compliance with the International Standard\n      ANSI/AAMI/ISO 81060-2 - Non-invasive sphygmomanometers - Clinical validation of automated\n      measurement type.\n\n      This clinical investigation will enrol up to 96 male and female subjects to ensure the\n      recording of 85/35 evaluable datasets in accordance with the ANSI/AAMI/ISO standard [11].\n      All measurements will be paired and falls into 2 categories: Auscultatory measurements as\n      gold standard reference, oscillometric measurements for clinical practise reference and\n      further validation of ambulatory monitoring and pulse shape measurements."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  At least 30% of the subjects must be males (n=29)\n\n          -  At least 30% of the subjects must be female (n=29)\n\n          -  Age \u2265 18 years old\n\n          -  Limb size circumference \u2265 17 cm\n\n          -  Blood pressure distribution:\n\n          -  At least 25 % of the subjects should be hypertensive\n\n          -  At least 5 % of the subjects should be hypotensive\n\n        Exclusion Criteria:\n\n          -  Breached skin\n\n          -  Acknowledged pregnancy\n\n          -  Pacemaker\n\n          -  Diagnosed cardiac arrhythmia (tachycardia, bradycardia, atrial/ventricular\n             fibrillation)\n\n          -  Implanted metal in upper limb:\n\n               -  Elbow prosthesis\n\n               -  Shoulder prosthesis\n\n               -  Metal screws\n\n               -  Bone plates\n\n               -  Metal chips\n\n               -  Surgical clips\n\n               -  Implantable Cardiac Defibrillator (ICD)\n\n               -  Cardiac Resynchronization Therapy - Defibrillator (CRT-D)\n\n               -  Premature ventricular contractions (PVC)\n\n               -  Premature arterial contractions (PAC)\n\n               -  Sensitivity or allergy towards adhesives\n\n          -  Presence of an arterial-venous shunt\n\n          -  Recent axillary node dissection"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "0", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01954446", 
            "org_study_id": "DK011"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "ContiPress vs. 3M", 
                    "ContiPress vs. Mobil-O-Graph"
                ], 
                "description": "Conventional measuring of BP", 
                "intervention_name": "3M", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": [
                    "ContiPress vs. 3M", 
                    "ContiPress vs. Mobil-O-Graph"
                ], 
                "description": "New way of measuring BP - ContiPressTM\nInvestigational device", 
                "intervention_name": "ContiPressTM", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "ContiPress vs. Mobil-O-Graph", 
                "description": "2 different devices for oscillometric measurement of BP", 
                "intervention_name": "Mobil-O-Graph", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 26, 2013", 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Novel Non-interfering Arterial Blood Pressure Monitoring Device", 
        "overall_official": {
            "affiliation": "Odense University Hospital", 
            "last_name": "Michael H Olsen, Prof. MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Withdrawn", 
        "oversight_info": {
            "authority": "Denmark: Danish Health and Medicines Authority", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The reference measurements are compared with the measurements made by the investigational device", 
            "measure": "Accuracy of measurement", 
            "safety_issue": "No", 
            "time_frame": "Up to 4 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01954446"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "After removal of each investigational device the skin is assessed. Also participants are instructed to report any skin irritation to investigator", 
            "measure": "Skin irritation", 
            "safety_issue": "Yes", 
            "time_frame": "Up to 4 months"
        }, 
        "source": "Sense A/S", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sense A/S", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "September 2013", 
        "why_stopped": "The investigational devices need alterations before validation"
    }
}